http://www.cardiosource.org/science-and-quality/clinical-trials/a/avoid.aspx?WT.mc_id=Twitter
http://www.cardiosource.org/~/media...ls/AHA14/AVOID Presentation Slides AHA14.ashx
In a nutshell, patients in the O2 arm had a larger infarct with more adverse events both while in the hospital, and after discharge (including another MI).
But, the patients in the non-O2 arm had a higher mortality rate at discharge and 6 months, and appears a higher rate of cardiogenic shock
This only included patients who were not hypoxic, which is good, but the authors choose to use an admitted non-standard therapy (8lpm by facemask) instead of the standard 2-4lpm by cannula, which is bad.
Discuss.
http://www.cardiosource.org/~/media...ls/AHA14/AVOID Presentation Slides AHA14.ashx
In a nutshell, patients in the O2 arm had a larger infarct with more adverse events both while in the hospital, and after discharge (including another MI).
But, the patients in the non-O2 arm had a higher mortality rate at discharge and 6 months, and appears a higher rate of cardiogenic shock
This only included patients who were not hypoxic, which is good, but the authors choose to use an admitted non-standard therapy (8lpm by facemask) instead of the standard 2-4lpm by cannula, which is bad.
Discuss.